Revvity | PKI - 销售收入

股票价格
85.18
每天变化
-1.62 -1.87%
每月一次
0.47%
每年
-10.01%
Q2 预测
84.91


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 10.54B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


销售 更改 日
Agilent USD 1.8B 63M 2025-12
Align Technology USD 1.05B 54.3M 2025-12
Bio Techne USD 295.9M 9.34M 2025-12
Bio-Rad Laboratories USD 693.2M 40.2M 2025-12
Bruker USD 977.2M 116.7M 2025-12
Celltrion KRW 1.33T 0 2026-03
Charles River Laboratories USD 994.2M 5.8M 2025-12
Cspc Pharmaceutical CNY 6.11B 502.75M 2025-12
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 961M 57M 2025-12
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
Edwards Lifesciences USD 1.65B 80M 2026-03
Illumina USD 1.16B 80M 2025-12
Intuitive Surgical USD 2.77B 100M 2026-03
IQVIA Holdings USD 4.36B 260M 2025-12
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Laboratory Of America USD 3.52B 40M 2025-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Mesa Laboratories USD 62.84M 5.01M 2024-12
Mettler Toledo International USD 1.13B 100M 2025-12
Myriad Genetics USD 209.8M 4.1M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
OraSure Technologies USD 26.76M 322K 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Pharma Mar EUR 90.2M 54.5M 2025-12
Qiagen NV USD 419.22M 38.16M 2026-03
Quest Diagnostics USD 2.9B 90M 2026-03
Quidel USD 724M 24M 2025-12
Repligen USD 197.91M 8.91M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Tilray USD 217.51M 74.75M 2025-12
Waters USD 932M 132M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M 2025-09